Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||Advanced Solid Tumor||not applicable||ONCOS-102||Phase I||Actionable||In a Phase I trial, ONCOS-102 demonstrated safety and preliminary efficacy, resulted in disease control in 40% (4/10) of patients with advanced solid tumors, and a median overall survival of 9.3 months (PMID: 26981247).||26981247|